Clinical Trial Update: Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of cyclophosphamide, lenalidomide, and dexamethasone (CLD) for previously treated AL amyloidosis. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Amyloidosis | Phase 2 | Status: COMPLETED